Kratos director sells 5,000 shares under 10b5-1 plan
Kratos Defense & Security Solutions, Inc. director Scot B. Jarvis reported a planned sale of company stock.
Rhea-AI Filing Summary
Kratos Defense & Security Solutions, Inc. director Scot B. Jarvis reported a planned sale of company stock. On January 15, 2026, he sold 5,000 shares of common stock at a price of $120.18 per share in an open market transaction coded as a sale. The filing notes that this trade was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Jarvis on September 15, 2025, which is designed to allow insiders to sell shares according to a preset schedule. After this transaction, Jarvis directly beneficially owns 105,417 shares of Kratos common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $120.18 | $601K |
Footnotes (1)
- F1. This transaction was effected pursuant to a 10b5-1 plan adopted by the reporting person on September 15, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction in KTOS stock did Scot B. Jarvis report?
Director Scot B. Jarvis reported an open market sale of 5,000 shares of Kratos Defense & Security Solutions, Inc. common stock on January 15, 2026, coded as a sale.
Was the KTOS insider sale by Scot B. Jarvis under a Rule 10b5-1 plan?
Yes. The filing states that the 5,000-share sale was effected under a Rule 10b5-1 trading plan adopted by Scot B. Jarvis on September 15, 2025.
What is Scot B. Jarvis’s relationship to Kratos Defense & Security Solutions (KTOS)?
Scot B. Jarvis is identified in the filing as a director of Kratos Defense & Security Solutions, Inc. and is not reported as a 10% owner or officer.
Is the KTOS Form 4 filing for Scot B. Jarvis an individual or joint filing?
The document indicates that it is a Form filed by one reporting person, covering Scot B. Jarvis alone.
AI-generated analysis. How Rhea-AI works. Not financial advice.